搜尋





搜尋





市場行情
/
股票
/
atnm
/

Actinium Pharmaceuticals Inc

ATNM

添加自選

0.867USD

+0.012+1.42%

收盤 07-28 16:00（美東）報價延遲15分鐘

27.19M總市值

虧損本益比TTM

Actinium Pharmaceuticals Inc

0.867

+0.012+1.42%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

ATNM 利潤表

您可以在這裡找到Actinium Pharmaceuticals Inc的年度或季度收入報告，以深入了解Actinium Pharmaceuticals Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

FY2014Q4

FY2014Q3

FY2014Q2

FY2014Q1

FY2013Q4

FY2013Q3

FY2013Q2

FY2013Q1

FY2012Q4

FY2012Q3

FY2012Q2

FY2012Q1

營業總收入

--0.00

--90.00K

--0.00

-100.00%0.00

--0.00

--81.00K

-100.00%0.00

-80.69%45.00K

-83.08%45.00K

51.13%940.00K

--23.00K

--233.00K

--266.00K

--622.00K

--0.00

營業收入

--0.00

--90.00K

--0.00

-100.00%0.00

--0.00

--81.00K

-100.00%0.00

-80.69%45.00K

-83.08%45.00K

51.13%940.00K

--23.00K

--233.00K

--266.00K

--622.00K

--0.00

營業費用

-64.52%5.90M

-14.54%6.41M

-54.11%5.78M

-39.58%7.50M

73.37%16.64M

-28.00%7.50M

-12.19%12.60M

-20.61%12.42M

-17.15%9.60M

-7.68%10.42M

45.78%14.35M

98.13%15.64M

89.78%11.58M

39.90%11.29M

46.88%9.84M

47.82%7.89M

1.84%6.10M

25.42%8.07M

19.40%6.70M

14.56%5.34M

5.47%5.99M

38.88%6.43M

-15.62%5.61M

-8.34%4.66M

-0.29%5.68M

-27.19%4.63M

7.34%6.65M

3.53%5.09M

-10.30%5.70M

22.21%6.36M

-7.43%6.20M

-31.80%4.91M

-18.60%6.35M

-23.73%5.21M

-5.71%6.70M

4.13%7.20M

30.05%7.81M

38.76%6.83M

53.04%7.10M

-6.57%6.92M

-23.69%6.00M

-28.41%4.92M

-34.14%4.64M

67.35%7.40M

90.06%7.87M

363.01%6.87M

337.85%7.04M

199.85%4.42M

104.99%4.14M

-59.92%1.48M

-32.94%1.61M

75.81%1.48M

100.82%2.02M

--3.70M

--2.40M

--839.34K

--1.01M

研發費用

-45.44%4.20M

-10.68%4.30M

-56.54%4.25M

-44.71%4.88M

16.05%7.70M

-40.74%4.81M

-15.90%9.77M

-20.36%8.82M

-15.47%6.63M

10.71%8.12M

71.64%11.62M

137.69%11.08M

79.65%7.85M

35.40%7.33M

43.82%6.77M

28.39%4.66M

2.17%4.37M

16.75%5.42M

24.29%4.71M

3.51%3.63M

3.01%4.28M

37.51%4.64M

-21.57%3.79M

-12.51%3.51M

-4.27%4.15M

-33.39%3.37M

14.42%4.83M

20.59%4.01M

-2.91%4.34M

31.27%5.07M

-14.85%4.22M

-24.07%3.33M

-0.84%4.47M

-1.12%3.86M

-12.81%4.96M

5.57%4.38M

19.62%4.50M

50.26%3.90M

101.05%5.69M

8.08%4.15M

-7.00%3.77M

-35.57%2.60M

-25.05%2.83M

80.13%3.84M

154.67%4.05M

1272.67%4.03M

384.87%3.77M

318.38%2.13M

46.43%1.59M

-59.04%293.66K

-53.60%778.23K

-15.30%509.26K

144.04%1.09M

--717.03K

--1.68M

--601.27K

--444.89K

折舊攤銷及損耗

-85.85%29.00K

0.98%206.00K

1.98%206.00K

7.94%204.00K

-5.09%205.00K

2.51%204.00K

1.00%202.00K

-9.57%189.00K

18.68%216.00K

23.60%199.00K

-9.50%200.00K

16.11%209.00K

32.85%182.00K

17.52%161.00K

66.17%221.00K

39.53%180.00K

9.60%137.00K

14.17%137.00K

19.82%133.00K

19.44%129.00K

15.74%125.00K

14.99%120.00K

4.12%111.00K

2.62%108.00K

3.96%108.00K

724.53%104.36K

702.51%106.61K

721.16%105.24K

768.30%103.88K

31.36%12.66K

20.24%13.28K

-10.60%12.82K

-42.81%11.96K

-51.47%9.63K

-44.97%11.05K

-26.38%14.34K

15.45%20.92K

97.42%19.85K

19.37%20.08K

20.24%19.47K

74.31%18.12K

-28.81%10.06K

17.41%16.82K

101.12%16.19K

639.86%10.39K

805.45%14.13K

--14.33K

--8.05K

--1.41K

926.32%1.56K

-100.00%0.00

--152.00

--112.00

--159.00

--158.00

營業利潤

64.52%-5.90M

14.54%-6.41M

54.83%-5.69M

39.58%-7.50M

-73.37%-16.64M

27.44%-7.50M

12.19%-12.60M

20.61%-12.42M

17.15%-9.60M

8.40%-10.34M

-46.45%-14.35M

-99.26%-15.64M

-124.32%-11.58M

-40.30%-11.29M

-51.48%-9.80M

-54.68%-7.85M

3.87%-5.16M

-25.07%-8.05M

-15.25%-6.47M

-8.86%-5.08M

5.47%-5.37M

-38.88%-6.43M

15.62%-5.61M

8.34%-4.66M

0.29%-5.68M

27.19%-4.63M

-7.34%-6.65M

-3.53%-5.09M

10.30%-5.70M

-22.21%-6.36M

7.43%-6.20M

31.80%-4.91M

18.60%-6.35M

23.73%-5.21M

5.71%-6.70M

-4.13%-7.20M

-30.05%-7.81M

-38.76%-6.83M

-53.04%-7.10M

6.57%-6.92M

23.69%-6.00M

28.41%-4.92M

34.14%-4.64M

-67.35%-7.40M

-90.06%-7.87M

-363.01%-6.87M

-337.85%-7.04M

-199.85%-4.42M

-104.99%-4.14M

59.92%-1.48M

32.94%-1.61M

-75.81%-1.48M

-100.82%-2.02M

---3.70M

---2.40M

---839.34K

---1.01M

淨非營業利息收入（費用）

利息收入

--381.00K

-44.43%474.00K

-45.69%561.00K

-41.31%625.00K

----

-16.29%853.00K

-3.91%1.03M

131.02%1.06M

----

58.23%1.02M

230.77%1.07M

448.81%461.00K

1419.44%547.00K

1594.74%644.00K

606.52%325.00K

55.56%84.00K

-30.77%36.00K

-30.91%38.00K

-36.99%46.00K

45.95%54.00K

300.00%52.00K

77.19%55.00K

37.60%73.00K

-37.70%37.00K

-55.03%13.00K

--31.04K

--53.05K

--59.39K

--28.91K

----

利息費用

--0.00

-100.00%0.00

--0.00

----

--1.00K

--0.00

----

--0.00

-100.00%0.00

0.00%1.00K

-100.00%0.00

-50.00%1.00K

-66.67%1.00K

-50.00%2.00K

-40.00%3.00K

-17.41%4.00K

-23.27%4.00K

-28.26%4.00K

-15.68%5.00K

--4.84K

--5.21K

--5.58K

--5.93K

----

-100.00%0.00

--0.00

13.27%666.00

8.37%1.68K

-53.59%2.66K

-100.00%0.00

--588.00

--1.55K

--5.73K

--866.00

----

-100.00%0.00

-99.59%1.30K

-99.80%634.00

-99.82%575.00

--147.09K

--318.62K

--320.73K

--312.89K

出售證券收益

----

--1.00K

----

--1.00K

----

-50.00%2.00K

-40.00%3.00K

-17.41%4.00K

-23.27%4.00K

-28.26%4.00K

-15.68%5.00K

--4.84K

--5.21K

--5.58K

--5.93K

----

特殊收入（費用）

----

--0.00

----

-100.00%0.00

----

-70.71%38.41K

-25.99%372.12K

-49.37%149.59K

-115.99%-255.99K

108.09%131.13K

-27.58%502.78K

612.35%295.46K

-66.61%1.60M

-211.97%-1.62M

-28.28%694.21K

-100.73%-57.67K

138.18%4.80M

132.93%1.45M

411.17%967.89K

707.13%7.94M

-1041.25%-12.56M

-551.74%-4.40M

164.32%189.35K

-224.89%-1.31M

226.05%1.33M

--973.02K

---294.38K

---402.52K

--409.30K

-固定資產出售收益

----

--0.00

----

--0.00

----

--0.00

---4.12K

--0.00

稅前利潤

65.35%-5.52M

10.70%-5.94M

55.64%-5.13M

39.42%-6.88M

-83.83%-15.94M

28.66%-6.65M

12.87%-11.57M

25.22%-11.35M

21.45%-8.67M

12.43%-9.32M

-40.13%-13.28M

-95.46%-15.18M

-115.19%-11.04M

-32.92%-10.65M

-47.50%-9.47M

-54.69%-7.77M

3.59%-5.13M

-25.55%-8.01M

-15.94%-6.42M

-8.56%-5.02M

6.17%-5.32M

-38.62%-6.38M

16.05%-5.54M

8.00%-4.63M

0.01%-5.67M

27.17%-4.60M

-7.34%-6.60M

-3.38%-5.03M

10.33%-5.67M

-22.40%-6.32M

2.76%-6.15M

31.06%-4.86M

21.56%-6.32M

22.89%-5.16M

4.18%-6.32M

-6.49%-7.05M

-83.08%-8.06M

-2.37%-6.70M

-67.22%-6.60M

11.25%-6.62M

-43.20%-4.40M

-20.54%-6.54M

35.06%-3.95M

-312.33%-7.46M

81.59%-3.07M

7.72%-5.43M

-327.68%-6.08M

226.26%3.52M

-2323.63%-16.70M

-104.36%-5.88M

52.83%-1.42M

-78.17%-2.78M

24.19%-689.03K

---2.88M

---3.01M

---1.56M

---908.91K

所得稅

----

--0.00

----

--0.00

----

--0.00

----

--0.00

----

--0.00

除稅後利潤

65.35%-5.52M

10.70%-5.94M

55.64%-5.13M

39.42%-6.88M

-83.83%-15.94M

28.66%-6.65M

12.87%-11.57M

25.22%-11.35M

21.45%-8.67M

12.43%-9.32M

-40.13%-13.28M

-95.46%-15.18M

-115.19%-11.04M

-32.92%-10.65M

-47.50%-9.47M

-54.69%-7.77M

3.59%-5.13M

-25.55%-8.01M

-15.94%-6.42M

-8.56%-5.02M

6.17%-5.32M

-38.62%-6.38M

16.05%-5.54M

8.00%-4.63M

0.01%-5.67M

27.17%-4.60M

-7.34%-6.60M

-3.38%-5.03M

10.33%-5.67M

-22.40%-6.32M

2.76%-6.15M

31.06%-4.86M

21.56%-6.32M

22.89%-5.16M

4.18%-6.32M

-6.49%-7.05M

-83.08%-8.06M

-2.37%-6.70M

-67.22%-6.60M

11.25%-6.62M

-43.20%-4.40M

-20.54%-6.54M

35.06%-3.95M

-312.33%-7.46M

81.59%-3.07M

7.72%-5.43M

-327.68%-6.08M

226.26%3.52M

-2323.63%-16.70M

-104.36%-5.88M

52.83%-1.42M

-78.17%-2.78M

24.19%-689.03K

---2.88M

---3.01M

---1.56M

---908.91K

持續經營利潤

65.35%-5.52M

10.70%-5.94M

55.64%-5.13M

39.42%-6.88M

-83.83%-15.94M

28.66%-6.65M

12.87%-11.57M

25.22%-11.35M

21.45%-8.67M

12.43%-9.32M

-40.13%-13.28M

-95.46%-15.18M

-115.19%-11.04M

-32.92%-10.65M

-47.50%-9.47M

-54.69%-7.77M

3.59%-5.13M

-25.55%-8.01M

-15.94%-6.42M

-8.56%-5.02M

6.17%-5.32M

-38.62%-6.38M

16.05%-5.54M

8.00%-4.63M

0.01%-5.67M

27.17%-4.60M

-7.34%-6.60M

-3.38%-5.03M

10.33%-5.67M

-22.40%-6.32M

2.76%-6.15M

31.06%-4.86M

21.56%-6.32M

22.89%-5.16M

4.18%-6.32M

-6.49%-7.05M

-83.08%-8.06M

-2.37%-6.70M

-67.22%-6.60M

11.25%-6.62M

-43.20%-4.40M

-20.54%-6.54M

35.06%-3.95M

-312.33%-7.46M

81.59%-3.07M

7.72%-5.43M

-327.68%-6.08M

226.26%3.52M

-2323.63%-16.70M

-104.36%-5.88M

52.83%-1.42M

-78.17%-2.78M

24.19%-689.03K

---2.88M

---3.01M

---1.56M

---908.91K

反常淨利潤

----

--0.00

----

歸属于母公司的淨利潤

65.35%-5.52M

10.70%-5.94M

55.64%-5.13M

39.42%-6.88M

-83.83%-15.94M

28.66%-6.65M

12.87%-11.57M

25.22%-11.35M

21.45%-8.67M

12.43%-9.32M

-40.13%-13.28M

-95.46%-15.18M

-115.19%-11.04M

-32.92%-10.65M

-47.50%-9.47M

-54.69%-7.77M

3.59%-5.13M

-25.55%-8.01M

-15.94%-6.42M

-8.54%-5.02M

6.17%-5.32M

-38.62%-6.38M

16.05%-5.54M

8.00%-4.63M

0.01%-5.67M

27.17%-4.60M

-7.34%-6.60M

-3.40%-5.03M

10.33%-5.67M

-22.40%-6.32M

2.76%-6.15M

31.06%-4.86M

21.56%-6.32M

22.89%-5.16M

4.18%-6.32M

-6.49%-7.05M

-83.08%-8.06M

-2.37%-6.70M

-67.22%-6.60M

11.25%-6.62M

-43.20%-4.40M

-20.54%-6.54M

35.06%-3.95M

-312.33%-7.46M

81.59%-3.07M

7.72%-5.43M

-327.68%-6.08M

226.26%3.52M

-2323.63%-16.70M

-104.36%-5.88M

52.83%-1.42M

-78.17%-2.78M

24.19%-689.03K

---2.88M

---3.01M

---1.56M

---908.91K

歸屬普通股東的淨利潤

65.35%-5.52M

10.70%-5.94M

55.64%-5.13M

39.42%-6.88M

-83.83%-15.94M

28.66%-6.65M

12.87%-11.57M

25.22%-11.35M

21.45%-8.67M

12.43%-9.32M

-40.13%-13.28M

-95.46%-15.18M

-115.19%-11.04M

-32.92%-10.65M

-47.50%-9.47M

-54.69%-7.77M

3.59%-5.13M

-25.55%-8.01M

-15.94%-6.42M

-8.54%-5.02M

6.17%-5.32M

-38.62%-6.38M

16.05%-5.54M

8.00%-4.63M

0.01%-5.67M

27.17%-4.60M

-7.34%-6.60M

-3.40%-5.03M

10.33%-5.67M

-22.40%-6.32M

2.76%-6.15M

31.06%-4.86M

21.56%-6.32M

22.89%-5.16M

4.18%-6.32M

-6.49%-7.05M

-83.08%-8.06M

-2.37%-6.70M

-67.22%-6.60M

11.25%-6.62M

-43.20%-4.40M

-20.54%-6.54M

35.06%-3.95M

-312.33%-7.46M

81.59%-3.07M

7.72%-5.43M

-327.68%-6.08M

226.26%3.52M

-2323.63%-16.70M

-104.36%-5.88M

52.83%-1.42M

-78.17%-2.78M

24.19%-689.03K

---2.88M

---3.01M

---1.56M

---908.91K

基本每股收益

65.40%-0.18

10.68%-0.19

55.82%-0.16

41.54%-0.22

-64.33%-0.51

37.29%-0.21

24.12%-0.37

34.87%-0.38

27.62%-0.31

18.61%-0.34

-30.32%-0.49

-76.92%-0.58

-85.44%-0.43

-15.19%-0.42

-26.25%-0.38

-31.87%-0.33

20.00%-0.23

9.59%-0.36

16.93%-0.30

97.97%-0.25

70.55%-0.29

52.12%-0.40

70.38%-0.36

-1125.23%-12.20

32.27%-0.98

49.35%-0.84

27.42%-1.21

24.69%-1.00

32.34%-1.45

14.40%-1.65

36.14%-1.67

63.66%-1.32

50.43%-2.15

46.65%-1.93

37.06%-2.61

14.95%-3.64

-44.95%-4.33

23.55%-3.62

-44.46%-4.15

30.00%-4.28

-7.61%-2.98

13.19%-4.74

55.05%-2.88

-249.44%-6.11

86.03%-2.77

26.36%-5.46

-254.24%-6.40

208.56%4.09

-1955.08%-19.86

82.76%-7.41

98.40%-1.81

-36.73%-3.77

51.45%-0.97

---42.97

---112.71

---2.75

---1.99

稀釋每股收益

65.40%-0.18

10.68%-0.19

55.82%-0.16

41.54%-0.22

-64.33%-0.51

37.29%-0.21

24.12%-0.37

34.87%-0.38

27.62%-0.31

18.61%-0.34

-30.32%-0.49

-76.92%-0.58

-85.44%-0.43

-15.19%-0.42

-26.25%-0.38

-31.87%-0.33

20.00%-0.23

9.59%-0.36

16.93%-0.30

97.97%-0.25

70.55%-0.29

52.12%-0.40

70.38%-0.36

-1125.23%-12.20

32.27%-0.98

49.35%-0.84

27.42%-1.21

24.69%-1.00

32.34%-1.45

14.40%-1.65

36.14%-1.67

63.66%-1.32

50.43%-2.15

46.65%-1.93

37.06%-2.61

14.95%-3.64

-44.95%-4.33

23.55%-3.62

-44.46%-4.15

30.00%-4.28

-7.61%-2.98

13.19%-4.74

55.05%-2.88

-307.75%-6.11

86.03%-2.77

26.36%-5.46

-254.24%-6.40

178.08%2.94

-1955.08%-19.86

82.76%-7.41

98.40%-1.81

-36.73%-3.77

51.45%-0.97

---42.97

---112.71

---2.75

---1.99

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Actinium Pharmaceuticals Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 ATNM 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Actinium Pharmaceuticals Inc 財年末的營收是多少？



Actinium Pharmaceuticals Inc 2025 財年營收為 90.00K，高於上一財年的 90.00K。

Actinium Pharmaceuticals Inc 全年的淨利潤是多少？



Actinium Pharmaceuticals Inc 2025 財年淨利潤為 -33.89M。

Actinium Pharmaceuticals Inc 上一季度的淨利潤是多少？



Actinium Pharmaceuticals Inc 最近一個季度的淨利潤為 -5.52M。

Actinium Pharmaceuticals Inc 年度營業利潤是多少？



Actinium Pharmaceuticals Inc 2025 財年的營業利潤為 -36.25M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。